Carlson R P, O'Neill-Davis L, Lewis A J
Int Arch Allergy Appl Immunol. 1985;76(1):89-90. doi: 10.1159/000233669.
Wy-41,195 demonstrated significant inhibitory effects (54-60%) when administered topically at 0.25-2% concentrations in a rat passive eyelid anaphylaxis assay. In contrast, topically applied disodium cromoglycate (DSCG) showed non significant inhibition at these concentrations. The potency of Wy-41,195 was more than 8 times greater than DSCG, and this compound may be an effective topical agent in man in preventing allergic and associated conditions.
在大鼠被动眼睑过敏试验中,Wy - 41,195以0.25% - 2%的浓度局部给药时显示出显著的抑制作用(54% - 60%)。相比之下,局部应用的色甘酸钠二钠(DSCG)在这些浓度下显示出不显著的抑制作用。Wy - 41,195的效力比DSCG大8倍以上,这种化合物可能是一种有效的局部用药,可用于预防人类的过敏及相关病症。